Lung Cancer

1

Novel EGFR mutation-specific antibodies for lung adenocarcinoma: Highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry

Seo, An Na, Park, Tae-In, Jin, Yan, Sun, Ping-Li, Kim, Hyojin, Chang, Hyun, Chung, Jin-Haeng

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1.32 MB

english, 2014

2

Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients – Analysis based on the National Lung Cancer Audit

Beckett, P., Tata, L.J., Hubbard, R.B.

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 404 KB

english, 2014

3

Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer

Kimura, Hideharu, Ohira, Tatsuo, Uchida, Osamu, Matsubayashi, Jun, Shimizu, Shinichiro, Nagao, Toshitaka, Ikeda, Norihiko, Nishio, Kazuto

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 605 KB

english, 2014

4

Editorial Board

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 58 KB

english, 2014

5

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma

Kim, Min Hwan, Shim, Hyo Sup, Kang, Dae Ryong, Jung, Ji Ye, Lee, Chang Young, Kim, Dae Joon, Lee, Jin Gu, Bae, Mi Kyung, Kim, Hye Ryun, Lim, Sun Min, Kim, Eun Young, Park, Ji Soo, Chung, Kyung Young,

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1007 KB

english, 2014

6

Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: A registry study

Rasmussen, Jakob F., Siersma, Volkert, Pedersen, Jesper H., Heleno, Bruno, Saghir, Zaigham, Brodersen, John

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1006 KB

english, 2014

7

Association of Merkel cell polyomavirus infection with EGFR mutation status in Chinese non-small cell lung cancer patients

Xu, Songxiao, Jiang, Junchang, Yu, Xiaoli, Sheng, Danli, Zhu, Tao, Jin, Mei

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 845 KB

english, 2014

8

Molecular testing in oncology: Problems, pitfalls and progress

O’Brien, Cathal P., Taylor, Sarah E., O’Leary, John J., Finn, Stephen P.

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1.25 MB

english, 2014

9

Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)

Reinmuth, N., Meyer, A., Hartwigsen, D., Schaeper, C., Huebner, G., Skock-Lober, R., Bier, A., Gerecke, U., Held, C.-P., Reck, M.

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 682 KB

english, 2014

10

Treatment and survival disparities in lung cancer: The effect of social environment and place of residence

Johnson, Asal Mohamadi, Hines, Robert B., Johnson, James Allen, Bayakly, A. Rana

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 651 KB

english, 2014

11

Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma

Kim, Hye Ryun, Cho, Byoung Chul, Shim, Hyo Sup, Lim, Sun Min, Kim, Se Kyu, Chang, Joon, Kim, Dae Joon, Kim, Joo Hang

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1.05 MB

english, 2014

12

Epithelial–myoepthelial carcinoma of the tracheobronchial tree: The prognostic role of myoepithelial cells

Song, Dae Hyun, Choi, In Ho, Ha, Sang Yun, Han, Kang Min, Han, Joungho, Kim, Tae-Sung, Kim, Jhingook, Kim, Hojoong

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1.64 MB

english, 2014

13

Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

Macerelli, M., Caramella, C., Faivre, L., Besse, B., Planchard, D., Polo, V., Ngo Camus, M., Celebic, A., Koubi-Pick, V., Lacroix, L., Pignon, J.P., Soria, J.C.

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 924 KB

english, 2014

15

The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation

Duruisseaux, Michael, Antoine, Martine, Rabbe, Nathalie, Poulot, Virginie, Fleury-Feith, Jocelyne, Vieira, Thibault, Lavolé, Armelle, Cadranel, Jacques, Wislez, Marie

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1.46 MB

english, 2014

16

High-dose, conventionally fractionated thoracic reirradiation for lung tumors

Griffioen, Gwendolyn H.M.J., Dahele, Max, de Haan, Patricia F., van de Ven, Peter M., Slotman, Ben J., Senan, Suresh

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 1.16 MB

english, 2014

17

How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study

Husain, Aliya N., Mirza, M. Kamran, Gibbs, Allen, Hiroshima, Kenzo, Chi, Yiqing, Boumendjel, Redouane, Stang, Nolwenn, Krausz, Thomas, Galateau-Salle, Francoise

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 3.32 MB

english, 2014

18

A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805)

Zhou, Qing, Zhou, Cai-cun, Chen, Gong-yan, Cheng, Ying, Huang, Cheng, Zhang, Li, Xu, Chong-rui, Li, Ai-wu, Yan, Hong-hong, Su, Jian, Zhang, Xu-chao, Yang, Jin-ji, Wu, Yi-long

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 661 KB

english, 2014

19

Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient

Pircher, A., Manzl, C., Fiegl, M., Popper, H., Pirker, R., Hilbe, W.

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 936 KB

english, 2014

20

Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement

Ha, Sang Yun, Choi, In Ho, Han, Joungho, Choi, Yoon-la, Cho, Jong Ho, Lee, Kyung-Jong, Sun, Jong-Mu

Journal:

Lung Cancer

Year:

2014

Language:

english

File:

PDF, 3.15 MB

english, 2014

Volume 83; Issue 3

Novel EGFR mutation-specific antibodies for lung adenocarcinoma: Highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry

Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients – Analysis based on the National Lung Cancer Audit

Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer

Editorial Board

Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma

Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: A registry study

Association of Merkel cell polyomavirus infection with EGFR mutation status in Chinese non-small cell lung cancer patients

Molecular testing in oncology: Problems, pitfalls and progress

Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)

Treatment and survival disparities in lung cancer: The effect of social environment and place of residence

Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma

Epithelial–myoepthelial carcinoma of the tracheobronchial tree: The prognostic role of myoepithelial cells

Contents

Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation

High-dose, conventionally fractionated thoracic reirradiation for lung tumors

How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study

A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805)

Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient

Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement